Latest News about BPMC
Recent news which mentions BPMC
Blueprint Medicines Highlights Detailed Data From Lead Product In Blood Cancer Patients
February 27, 2023
From Benzinga
From Benzinga
Earnings Scheduled For February 16, 2023
February 16, 2023
From Benzinga
FDA Slaps Partial Clinical Hold On Blueprint Medicines' Early-Stage Solid Tumor Study
February 10, 2023
Tickers
BPMC
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022
December 14, 2022
From Benzinga
Blueprint Medicines's Return On Capital Employed Overview
November 07, 2022
Tickers
BPMC
From Benzinga
Blueprint Medicines Stock Gets Price Target Cut Amid Lower Than Expected Ayvakit Uptake
November 02, 2022
Tickers
BPMC
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2022
November 02, 2022
From Benzinga
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2022
September 14, 2022
From Benzinga
What 14 Analyst Ratings Have To Say About Blueprint Medicines
August 22, 2022
Tickers
BPMC
From Benzinga
From Benzinga
Blueprint Medicines' Ayvakit 'Will Garner Approval' Despite Questions, This Analyst Says
August 18, 2022
Tickers
BPMC
From Benzinga
From Benzinga
Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary
August 17, 2022
From Benzinga
Analyst Sees Deteriorated Treatment Effect Of Blueprint's Much Awaited Mastocytosis Data
August 17, 2022
Tickers
BPMC
From Benzinga
From Benzinga
Why Blue Water Vaccines Is Trading Higher By Around 80%, Here Are 61 Stocks Moving In Wednesday's Mid-Day Session
August 17, 2022
From Benzinga
U.S. Stocks Open Lower; Nasdaq Down 150 Points
August 17, 2022
From Benzinga
Blueprint Medicines Shares Fall After Topline Results From Late-Stage Neoplastic Disorder Study
August 17, 2022
Tickers
BPMC
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.